Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement...
11 Fevereiro 2019 - 7:21PM
Edgar (US Regulatory)
February 11, 2019
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. St., N.E.
Washington, D.C. 20549
|
Re:
|
Delaying Amendment for Registration Statement on Form S-1
(File No. 333-228044) of Bionik Laboratories Corp. (the “Registrant”)
|
Ladies and Gentlemen:
Pursuant to Rule
473(c) of the Securities Act of 1933, as amended (the “Securities Act”), the following delaying amendment, prescribed
by Rule 473(a) of the Securities Act, is hereby incorporated into the facing page of the Registration Statement on Form S-1 (File
No. 333-228044), filed by Bionik Laboratories Corp. on January 23, 2019:
“The Registrant hereby
amends this Registration Statement on Form S-1 on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such
date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.”
If you have any
questions or comments in connection with this delaying amendment, please contact Stephen E. Fox of Ruskin Moscou Faltischek, P.C.,
the Company’s counsel, at (516) 663-6580.
|
Very truly yours,
|
|
|
|
|
|
BIONIK LABORATORIES CORP.
|
|
|
|
|
|
By:
/s/ Leslie Markow
|
|
|
Name: Leslie Markow
|
|
|
Title: Chief Financial Officer
|
|
Bionik Laboratories (CE) (USOTC:BNKL)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Bionik Laboratories (CE) (USOTC:BNKL)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Bionik Laboratories Corporation (CE) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Bionik Laboratories Corp.